HRT Financial’s Nexalin Technology NXL Stock Holding History

HRT Financial’s Portfolio NXL Stock Details NXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-782	Closed	-$8K	–	5011
2026 Q1	$8K	Buy	+782	New	+$12.2K	﹤0.01%	3649

Other funds holding NXL

PEAK6 Chicago, Illinois $48.6B AUM 40.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HRT Financial's NXL Position: Q2 2026 in Review

HRT Financial sold out of Nexalin Technology (NXL) in Q2 2026, closing a stake of 782 shares — an estimated $8K sold.

HRT Financial first reported a position in NXL in Q1 2026 and held it in 1 quarter. The position peaked at $8K in Q1 2026. 20 funds tracked by Wall St. Rank hold NXL as of Q2 2026.

HRT Financial reported no remaining Nexalin Technology position as of Q2 2026 after selling out during the quarter.
HRT Financial sold 782 Nexalin Technology shares in Q2 2026, an estimated $8K.
HRT Financial first reported a position in Nexalin Technology in Q1 2026 and held it in 1 quarter.
HRT Financial's Nexalin Technology position peaked at $8K in Q1 2026.
20 funds tracked by Wall St. Rank held Nexalin Technology as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.